Genomic testing for sensitivity of breast cancer to hormonal therapy

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1954-5. doi: 10.1158/1078-0432.CCR-06-0289.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Chemotherapy, Adjuvant
  • Drug Resistance, Neoplasm / genetics*
  • Female
  • Gene Expression Profiling
  • Genetic Markers / genetics
  • Homeodomain Proteins / genetics*
  • Humans
  • Receptors, Interleukin / genetics*
  • Receptors, Interleukin-17
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sensitivity and Specificity

Substances

  • Antineoplastic Agents, Hormonal
  • Genetic Markers
  • HOXB13 protein, human
  • Homeodomain Proteins
  • IL17RB protein, human
  • Receptors, Interleukin
  • Receptors, Interleukin-17